Canada
· Delayed Price · Currency is CAD Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of CAD 29.21 million. The enterprise value is 130.35 million.
| Market Cap | 29.21M |
| Enterprise Value | 130.35M |
Important Dates
The next estimated earnings date is Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Conavi Medical has 44.25 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 44.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | n/a |
| Float | 12.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.88 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.99 |
| EV / Sales | 60.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.29 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.01 |
| Interest Coverage | -3.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -98.23% |
| Return on Invested Capital (ROIC) | -251.52% |
| Return on Capital Employed (ROCE) | 133.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.96 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 39.87 |
| Average Volume (20 Days) | 6,304 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of CAD 2.16 million and -43.62 million in losses. Loss per share was -7.08.
| Revenue | 2.16M |
| Gross Profit | 53,000 |
| Operating Income | -26.23M |
| Pretax Income | -43.62M |
| Net Income | -43.62M |
| EBITDA | -25.60M |
| EBIT | -26.23M |
| Loss Per Share | -7.08 |
Balance Sheet
The company has 436,000 in cash and 83.18 million in debt, giving a net cash position of -82.74 million or -1.87 per share.
| Cash & Cash Equivalents | 436,000 |
| Total Debt | 83.18M |
| Net Cash | -82.74M |
| Net Cash Per Share | -1.87 |
| Equity (Book Value) | -85.83M |
| Book Value Per Share | -16.92 |
| Working Capital | -24.67M |
Cash Flow
In the last 12 months, operating cash flow was -20.15 million and capital expenditures -576,000, giving a free cash flow of -20.72 million.
| Operating Cash Flow | -20.15M |
| Capital Expenditures | -576,000 |
| Free Cash Flow | -20.72M |
| FCF Per Share | -0.47 |
Margins
| Gross Margin | 2.45% |
| Operating Margin | -1,213.93% |
| Pretax Margin | -2,018.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -149.34% |
| FCF Yield | -70.96% |
Stock Splits
The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.04.
| Last Split Date | Oct 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
Conavi Medical has an Altman Z-Score of -37.27. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.27 |
| Piotroski F-Score | n/a |